RPL39 (Ribosomal Protein L39) is a component of the 60S ribosomal subunit and belongs to the L39e family of ribosomal proteins[@structure2020][@ribosomal2022]. Found in the ribosomal large subunit, RPL39 contributes to protein synthesis machinery essential for all cellular functions. The gene is located on the X chromosome (Xq21.1) and is highly conserved across species, reflecting its fundamental role in cellular biology.
RPL39 (Ribosomal Protein L39) is a component of the 60S ribosomal subunit and belongs to the L39e family of ribosomal proteins[@structure2020][@ribosomal2022]. Found in the ribosomal large subunit, RPL39 contributes to protein synthesis machinery essential for all cellular functions. The gene is located on the X chromosome (Xq21.1) and is highly conserved across species, reflecting its fundamental role in cellular biology.
While ribosomal proteins were historically viewed as structural components of the translation apparatus, research has revealed that RPL39, like other ribosomal proteins, can have extra-ribosomal functions including roles in development, stress response, and disease[@extraribosomal2021].
Structure
RPL39 is a small protein of approximately 51 amino acids with distinctive features:
Cysteine-rich domain: Contains multiple cysteine residues involved in zinc coordination
Zinc-binding motif: C4-type zinc finger for structural stabilization
Ribosomal interaction interface: Mediates binding to 28S rRNA
Ribosome stability: Maintains structural integrity of the large subunit
Extra-ribosomal Functions
Research has identified several non-canonical roles for RPL39:
Development: RPL39 is involved in embryonic development and cell differentiation
Stress response: Can be upregulated under cellular stress conditions
Gene expression: May influence translation of specific mRNA subsets
Signal transduction: Has been reported to interact with signaling pathways
Role in Disease
Diamond-Blackfan Anemia (DBA)
RPL39 mutations have been identified in a small subset of Diamond-Blackfan anemia cases[@genotypephenotype2023]. DBA is a congenital bone marrow failure syndrome characterized by impaired red blood cell production. RPL39-related DBA demonstrates the critical importance of ribosomal protein function in hematopoietic stem cell maintenance and erythropoiesis.
Cancer
RPL39 dysregulation has been implicated in various malignancies:
Overexpression: RPL39 is overexpressed in several cancer types
Oncogenic potential: Can promote cell proliferation and survival
Chemoresistance: Associated with treatment resistance in some cancers
Alternative splicing: Cancer-specific isoforms may alter function
Neurodegenerative Disease
Direct evidence linking RPL39 to AD or PD remains limited, but ribosomal dysfunction is a recognized feature of neurodegeneration:
Protein synthesis impairment: Reduced translation capacity in aging and diseased [neurons](/entities/neurons)
Ribosomal biogenesis defects: Altered ribosome assembly in neurodegenerative conditions
Stress granules: RPL39 may participate in stress granule formation
Oxidative damage: Ribosomal proteins are targets of oxidative modification
Therapeutic Relevance
Understanding RPL39 function offers potential therapeutic insights:
Ribosomal targeting: Cancer therapies targeting ribosomal function may exploit RPL39 differences
Translation modulation: Could inform strategies to restore neuronal protein synthesis
DBA treatment: RPL39 understanding may aid development of DBA therapies